Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 5:26 PM ET

Software

Company Overview of Vital Art and Science Inc.

Company Overview

Vital Art and Science Inc. develops a handheld application that is capable of diagnosing and monitoring age-related macular degeneration and diabetic retinopathy. The company develops myVisionTrack, which allows patients with age-related macular degeneration and diabetic retinopathy to test and monitor their retinal function at home. Vital Art and Science Inc. was founded in 2006 and is based in Garland, Texas.

5909 Indian Hills Drive

Garland, TX 75044

United States

Founded in 2006

Phone:

972-414-5464

Key Executives for Vital Art and Science Inc.

Vital Art and Science Inc. does not have any Key Executives recorded.

Vital Art and Science Inc. Key Developments

Vital Art and Science Releases Four New Studies in the Continuing Scientific Investigations of its Newly Launched mVT Service

Vital Art and Science, LLC (VAS) released four new studies in the continuing scientific investigations of its newly launched mVT Service, an innovative medical device that conveniently and accurately tracks the progression of maculopathies. The device, an easily downloaded app available by prescription only, showed value in features important in a screening tool - predictive response, stability of results, ability to detect visual function improvement, and reliability. The studies evaluated different features of the mVT Service. Researchers in San Francisco and Berkeley assessed the Service against nine other tools for predictive response, i.e. the ability to predict which patients are at the great risk of progressing to advanced disease. mVT showed the most predictive promise. The University of Liverpool researchers investigated the stability of mVT results. Stability prior to disease onset in at-risk eyes is essential for a reliable screening test; stability of the mVT was confirmed. The investigators also commented that unlike other tests, the mVT is convenient and users report no testing difficulties. The National Institutes of Health (NIH) supported a diabetic retinopathy study in Dallas to see if the mVT Service detects visual function improvement from anti-VEGF treatments. Results indicated that mVT clearly detects visual function improvement and, in fact, appears to be more sensitive than either visual acuity or letter contrast sensitivity in detecting changes. The last study, also supported by NIH, investigated the strength of the shape discrimination hyperacuity test methodology of the mVT. Results confirmed its reliability and accuracy. Researchers noted mVT should be especially valuable for longer duration treatments because of its convenient home monitoring. Age related macular degeneration is the leading cause of blindness for people over 60, and the diabetic retinopathy population continues to grow with the increasing prevalence of diabetes. The new mVT Service is the only simple, FDA-cleared, low cost, mobile, validated method available for these patients to test their vision at home. Patients take a simple 4-6 minute self-test, performed on the timetable recommended by the doctor (usually twice a week). Patient test results are automatically delivered to a HIPAA-compliant database and analyzed for prescriber review.

Similar Private Companies By Industry

Company Name Region
Zyrion, Inc. United States
Escrow Associates, an NCC Group Company United States
Pacific Digital U.S.A Corp. United States
Emtec Global Services LLC United States
Motionplan, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vital Art and Science Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.